19937 results for «»

Filter By

19937 results

Daniela Yasmin Seubert

Stuttgart, Germany

Left main stem percutaneous coronary intervention: does on-site surgical cover make a difference?

28 Oct 2022

The current analysis examines patient characteristics and outcomes following LM PCI performed in NSC in England and Wales.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Turki B Albacker

Reviewer

Turki B Albacker
Left main stem percutaneous coronary intervention: does on-site surgical cover make a difference?

Turki B Albacker

Riyadh, Saudi Arabia

Turki B Albacker

Mingming Yang

Glasgow, United Kingdom

Radial approach in complex angioplasty: from the puncture to the haemostasis

31 Oct 2022

View this replay of a LIVE demonstration on mastering the essentials of a successful complex PCI by using radial approach, wiht operators J. Monségu and B. Faurie.

PCR Webinar on Demand: radial approach in complex angioplasty

Drug Coated Balloons 2021-2022

31 Oct 2022

Find out more about this new series of 2 PCR Webinars on drug coated balloons

Drug Coated Balloons Coronary Intervention Series

#1 - How should I treat a patient with in-stent restenosis ?

31 Oct 2022

Discover the replay of this PCR Webinar on drug-coated-balloons with F. Ribichini, B. Scheller and A. G. Zaman

How should I treat a patient with in-stent restenosis ?

How and when should I consider Drug Coated Balloons to treat de novo lesions?

31 Oct 2022

Discover the replay of this PCR Webinar on Drug Coated Balloons with F. Ribichini, F. Manterola and D. Mylotte.

How and when should I consider Drug Coated Balloons to treat de novo lesions ?

Clement Tan

Hamilton, New Zealand

A patient with ACS – how should I treat the left main?

31 Oct 2022

Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.

A patient with ACS – how should I treat the left main?

A patient with diabetes and diffuse coronary disease – how should I treat small vessels?

31 Oct 2022

For this 2nd PCR Webinar on the Road, join your duo of hosts D. Milasinovic and C. de Biase in the cathlab with A. Latib in New York, U.S.A

A patient with diabetes and diffuse disease – how should I treat small vessels?

A patient with a high-bleeding risk – how should I treat a calcified lesion?

31 Oct 2022

Discover the replay of this PCR Webinar on the Road and continue your world tour with a trip to Aalst, Belgium with E. Barbato, C. De Biase and D. Milasinovic

A patient with a high-bleeding risk – how should I treat a calcified lesion?

A patient undergoing TAVI - how should I achieve optimal coronary access?

31 Oct 2022

Our duo of hosts Dejan Milasinovic and Chiara de Biase visit the cathlab of Khaled Al-Shaibi, based in Jeddah, Saudi Arabia.

A patient undergoing TAVI- how should we achieve optimal coronary access?

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

31 Oct 2022

Discover the replay of this PCR Webinar on the Road in Verona, Italy on aortic stenosis with D. Milasinovic, C. de Biase and F. Ribichini.

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

Matthias Riebisch

Essen, Germany

SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease

02 Nov 2022

AHA 2022: get the interventional cardiology perspective!

07 Nov 2022

Stay up to date with what is new and hot in interventional cardiology at #AHA22 in Chicago.

PCRonline @ AHA 2022

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

08 Nov 2022

Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.

Author

Ali Nazmi Calik
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
Didn’t find what you were looking for?